InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
60,987.11
(
0.32%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

kei

Send PM Follow Ignore
Followers 306
Posts 22916
Boards Moderated 0
Alias Born 10/10/2007

kei

Re: kei post# 84737

Friday, 12/19/2014 7:25:51 AM

Friday, December 19, 2014 7:25:51 AM

Post# of 97237
OREX - Orexigen's Mysimba™ (naltrexone HCl / bupropion HCl prolonged release) Receives Positive CHMP Opinion Recommending Approval for Weight Management in the European Union

http://finance.yahoo.com/news/orexigens-mysimba-naltrexone-hcl-bupropion-121900320.html

now, imo, earning next year like 2nd q 3rdq 4thq will be very interesting since takeda will push their products in eu

°°° (\__/) (\_(\ ° ° °
°°° (='.'=) (=' :') °°°
°°° (")_(") (,(')(')°°°
°°° °°° °°° °°° °°°


Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up